Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample technologies (+3% CER) Solid adjusted operating income margin at 29.6% Adjusted diluted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback